Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor

Nuclear Medicine and Biology

Volumn 36, Issue 8, 2009, Pages 907-917

  Armstrong, Andrea F ^a   Lemon, Jennifer A ^a   Czorny, Shannon K ^a,d   Singh, Gurmit ^d   Valliant, John F ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

99mTc; Cyclic peptide; Regioselective; Resin capture; SAAC; uPAR

Indexed keywords

2 PYRIDYL TECHNETIUM 99M; 2 THIAZOLYL TECHNETIUM 99M; 3 PYRIDYL TECHNETIUM 99M; 6 METHOXY 2 PYRIDYL TECHNETIUM 99M; LYSINE DERIVATIVE; N METHYLIMIDAZOLYL TECHNETIUM 99M; QUINOLYL TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISULFIDE BOND; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ISOTOPE LABELING; PROTEIN DETERMINATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY;

AMINO ACIDS; CHELATING AGENTS; HUMANS; ISOTOPE LABELING; PEPTIDES, CYCLIC; RADIOPHARMACEUTICALS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; TECHNETIUM; U937 CELLS;

EID: 70350648338     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.07.001     Document Type: Article

References (48)

1. Bailey D.L., and Meikle S.R. SPECT: basic science and clinical application (2008), Springer Press
2. In: Israel O., and Goldsmith S.J. (Eds). Hybrid SPECT/CT imaging in clinical practice (2006), Informa Healthcare, New York, NY
3. In: von Schulthess G.K. (Ed). Molecular anatomic imaging: PET-CT and SPECT-CT integrated modality imaging. 2nd ed. (2006), Lippincott Williams & Wilkins, Philadelphia, PA
4. In: Wagner Jr. H.N., and Conti P.S. (Eds). PET-CT: a case based approach (2006), Springer Press, New York, NY
5. Schubiger P.A., Lehmann L., and Friebe M. PET chemistry: the driving force in molecular imaging (2006), Springer Press
6. Ametamey S.M., Honer M., and Schubiger P.A. Molecular imaging with PET. Chem Rev 108 (2008) 1501-1516
7. In: Welch M.J., and Redvanley C.S. (Eds). Handbook of Radiopharmaceuticals, Radiochemistry and Applications (2003), John Wiley and Sons, Ltd., West Sussex, England 772-790
8. Alberto R. New organometallic technetium complexes for radiopharmaceutical imaging. Top Curr Chem 252 (2005) 1-44
9. Okarvi S.M. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancer and other diseases. Med Res Rev 24 (2004) 357-397
10. Massoud T.F., and Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17 (2003) 545-580
11. Lundqvist H., and Tolmachev V. Targeting peptides and positron emission tomography. Biopolymers (Peptide Science) 66 (2002) 381-392
12. Kwekkeboom D., Krenning E.P., and De Jong M. Peptide receptor imaging and therapy. J Nucl Med 41 (2000) 1704-1713
13. In: Chan W.C., and White P.D. (Eds). Fmoc solid phase peptide synthesis: a practical approach (2000), Oxford University Press, New York 277-300
14. 99mTc-labeled monoclonal antibodies. J Nucl Med 28 (1987) 721
15. Mather S.J., and Ellison D. Reduction-mediated technetium-99m labelling of monoclonal antibodies. J Nucl Med 31 (1990) 692-697
16. Fridkin G., Bonsera T.A., Litman P., and Gilon C. Backbone-metal cyclization: a novel approach for the simultaneous peptide cyclization and radiolabelling. Application to the combinatorial synthesis of rhenium-cyclic somatostatin analogs. Nucl Med Biol 32 (2005) 39-50
17. Pietersz G.A., Patrick M.R., and Chester K.A. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. J Nucl Med 39 (1998) 47-56
18. Verhaar M.J., Keep P.A., Hawkins R.E., Robson L., Casey J.L., Pedley B., et al. Technetium-99m radiolabelling using a phage-derived single-chain Fv with a C-terminal cysteine. J Nucl Med 37 (1996) 868-872
19. George A.J.T., Jamar F., Tai M.S., Heelan B.T., Adams G.P., McCartney J.E., et al. Radiometal labelling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. Proc Natl Acad Sci U S A 92 (1995) 8358-8362
20. Nedelman M.A., Shealy D.J., Boulin R., Brunt E., Seasholtz J.I., Allen I.E., et al. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction. J Nucl Med 34 (1993) 234-241
21. Zamora P.O., and Rhodes B.A. Imidazoles as well as thiolates in proteins bind technetium-99m. Bioconj Chem 3 (1992) 493-498
22. 99mTc: a reflection on technetium core structures and a strategy for new chelate design. Nucl Med Biol 32 (2005) 1-20
23. De León-Rodríguez L.M., and Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconj Chem 19 (2008) 391-402
24. Korkmaz M., and Ozer A.Y. Technetium-99m-DTPA. Farmasotik Bilimler Dergisi 21 (1996) 105-110
25. Waibel R., Alberto R., Willuda J., Finnern R., Schibli R., Stichelberger A., et al. Stable one-step technetium-99m labelling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17 (1999) 897-901
26. Knight L.C., Baidoo K.E., Marmino M.E., and Romano J.E. Tc-99m Tricarbonyl labelling of DTPA-bitistatin for imaging thrombi and emboli. Nucl Med Commun 21 (2000) 589
27. 3] octreotate. J Label Compd Radiopharm 42 Suppl 1 (1999) 231-233
28. Djokić D., and Janković D. Biological evaluation and comparison of three different procedures for labelling of amino acids tyrosine and lysine with technetium-99m. J Label Compd Radiopharm 50 (2007) 155-163
29. 2)}].Inorg Chem 41 (2002) 6417-6425
30. Levadala M.K., Banerjee S.R., Maresca K.P., Babich J.W., and Zubieta J. Direct reductive alkylation of amino acids: synthesis of bifunctional chelates for nuclear imaging. Synthesis 11 (2004) 1759-1766
31. Schaffer P., Gleave J.A., Lemon J.A., Reid L.C., Pacey L.K.K., Farncombe T.H., et al. Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplants. Nucl Med Bio 35 (2008) 159-169
32. +]G. Bioconjugate Chem 15 (2004) 128-136
33. 99mTc complexes for correlating fluorescence and radioimaging studies. J Am Chem Soc 126 (2004) 8598-8599
34. 2Br]. Inorg Chem Commun 7 (2004) 1023-1026
35. Siu J., Baxendale I.R., Lewthwaite R.A., and Ley S.V.A. A phase-switch purification approach for the expedient removal of tagged reagents and scavengers following their application in organic synthesis. Org Biomol Chem 3 (2005) 3140-3160
36. 19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Biol Chem 382 (2001) 1197-1205
37. Sunstrom C., and Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17 (1976) 565-577
38. Ciccocioppo R., Capri M.G., and Alberti S. Detection of the receptor for the human urokinase-type plasminogen activator using fluoresceinated uPA. J Histochem Cytochem 45 (1997) 1307-1313
39. Picone R., Kajtaniak E.L., Nielsen L.S., Behrendt N., Mastronicola M.R., Cubellis M.V., et al. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J Cell Biol 108 (1989) 693-702
40. Armstrong A.F., Oakley N., Parker S., Causey P.W., Lemon J., Capretta A., et al. A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents. Chem Commun 43 (2008) 5532-5534
41. In: Tierney J.P., and Lidström P. (Eds). Microwave assisted organic synthesis (2005), Blackwell Publishing Ltd., Oxford
42. Rømer J., Nielsen B.S., and Ploug M. The urokinase receptor as a potential target in cancer therapy. Curr Pharm Des 10 (2004) 2359-2376
43. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev 3 (2002) 932-943
44. Sperl S., Mueller M.M., Wilhelm O.G., Schmitt M., Magdolen V., and Moroder L. The uPA/uPAR receptor system as a target for tumor therapy. Drug News Perspect 14 (2001) 401-411
45. Kilbourn M.R. Fluorine-18 labeling of radiopharmaceuticals. Prepared for the Committee on Nuclear and Radiochemistry, National Research Council (1990), National Academy Press, Washington, DC 17-18
46. Eckelman W.C., Bonardi M., and Volkert W.A. True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?. Nucl Med Biol 35 (2008) 523-527
47. Hilde L. George Hevesy and his concept of radioactive indicators-In retrospect. Eur J Nucl Med Molec Imag 1 (1976) 3-10
48. Causey P.W., Besanger T.R., Schaffer P., and Valliant J.F. The expedient multi-step synthesis of organometallic complexes of Tc and Re in high effective specific activity. A new platform for the production of molecular imaging and therapy agents. Inorg Chem 47 (2008) 8213-8221